Propofol Market Share

  • Report ID: 3132
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Propofol Industry - Regional Synopsis

North America Market Statistics

On the basis of regional analysis, the global propofol market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.  North America industry is expected to dominate majority revenue share by 2037, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

Europe Market Analysis

Furthermore, Europe is assessed to hold the second largest market share owing to the rising geriatric population in the region who need to be frequently operated with dental as well as ophthalmic surgical procedures. Additionally, increasing investments for drug development by market players in the region is also likely to fuel the propofol market growth in the region. 

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of propofol is assessed at USD 1.09 billion.

Propofol Market size was over USD 1.04 billion in 2024 and is projected to reach USD 2.01 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to dominate majority revenue share by 2037, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

The major players in the market are Pfizer Inc., Bachem Holding AG, Porton Fine Chemicals Ltd., SI Group, Inc., AstraZeneca plc, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos